Arcellx (ACLX) Non-cash Items (2021 - 2025)
Arcellx (ACLX) recorded quarterly Non-cash Items of $5.8 million in Q4 2025, down 98.61% quarter-over-quarter from $415.6 million in Q4 2024, and down 98.61% on a YoY basis from $415.6 million in Q4 2024.
Arcellx (ACLX) Non-cash Items (2021 - 2025) Analysis & Trends
Arcellx's Non-cash Items history runs 5 years deep, the most recent figure standing at $5.8 million for Q4 2025.
- In Q4 2025, Non-cash Items fell 98.61% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (down 98.61% YoY), while the FY2025 annual figure was $5.8 million, down 98.61% from the prior year.
- Non-cash Items was $5.8 million for Q4 2025 at Arcellx, down from $415.6 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $415.6 million in Q4 2024 to a low of $2.4 million in Q2 2022.
- Historically, Non-cash Items has averaged $122.7 million across 5 years, with a median of $44.6 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Non-cash Items jumped 6847.57% in 2023, then tumbled 98.61% in 2025.
- A 5-year view of Non-cash Items shows it stood at $7.3 million in 2021, then soared by 2244.46% to $172.3 million in 2022, then surged by 95.12% to $336.2 million in 2023, then increased by 23.64% to $415.6 million in 2024, then sank by 98.61% to $5.8 million in 2025.
- The last three Non-cash Items figures came in at $5.8 million (Q4 2025), $415.6 million (Q4 2024), and $336.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.79 Mn |
| Dec 31, 2025 | 5.79 Mn |
| Dec 31, 2024 | 415.63 Mn |
| Dec 31, 2024 | 415.63 Mn |
| Dec 31, 2023 | 336.17 Mn |
| Dec 31, 2023 | 336.17 Mn |
| Sep 30, 2023 | 191.98 Mn |
| Sep 30, 2023 | 191.98 Mn |
| Jun 30, 2023 | 167.17 Mn |
| Jun 30, 2023 | 167.17 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 172.29 Mn |
| Dec 31, 2022 | 172.29 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 44.63 Mn |
| Mar 31, 2022 | 44.63 Mn |